The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Whole Exome Sequencing Market By 2030 Starting From Its 2026 Size?
The whole exome sequencing market has witnessed significant expansion over recent years. It is anticipated to increase from $3.36 billion in 2025 to $4.06 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.0%. This historical growth can be attributed to several key factors, including the increasing accessibility of next-generation sequencing platforms, a rise in genetic disorder diagnoses, the expansion of academic genomic research, decreasing sequencing costs, and growing adoption within clinical laboratories.
The whole exome sequencing market is projected to experience substantial growth, reaching a value of $8.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.5%. This expansion over the forecast period is fueled by several factors, including the escalating demand for precision diagnostics, the broadening scope of genomic medicine initiatives, the deeper integration of sequencing data into clinical decision-making processes, growing investments in sequencing infrastructure, and the heightened uptake in drug discovery efforts. Key trends anticipated during this period encompass the wider adoption of exome-based diagnostic testing, the increasing application of sequencing in identifying rare diseases, the growing incorporation of bioinformatics analysis platforms, the proliferation of personalized medicine applications, and an intensified focus on developing cost-effective sequencing workflows.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp
What Drivers Are Shaping The Future Growth Of The Whole Exome Sequencing Market?
The rising prevalence of HIV, or human immunodeficiency virus, is anticipated to drive the expansion of the whole exome sequencing market in the coming period. This virus specifically targets the body’s immune system. Whole exome sequencing offers genomic insights into viruses, which are vital for developing personalized treatments and vaccines for HIV. As an illustration, the Minority HIV/AIDS Fund (MHAF), a US-based government agency, reported in August 2024 that an estimated 39.9 million people globally were living with HIV in 2023. This total included 38.6 million adults and 1.4 million children, marking an increase from prior years. Consequently, the escalating HIV prevalence is a key factor boosting the whole exome sequencing market’s growth.
Which Segment Categories Define The Whole Exome Sequencing Market?
The whole exome sequencing market covered in this report is segmented –
1) By Product: Systems, Kits, Services
2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research
4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users
Subsegments:
1) By Systems: Sequencing Systems, Data Analysis Systems
2) By Kits: Library Preparation Kits, Exome Enrichment Kits, Sequencing Kits
3) By Services: Data Analysis Services, Consulting Services, Custom Sequencing Services
How Are Trends Impacting The Whole Exome Sequencing Market?
Leading companies in the whole exome sequencing market are actively developing advanced next-generation sequencing (NGS) ultra-fast technology. This development aims to improve the speed and precision of genetic analysis, thus facilitating quicker diagnostics and personalized treatment plans in healthcare. This ultra-fast next-generation sequencing (NGS) technology enhances whole exome sequencing by rapidly analyzing exonic areas, enabling the swift identification of genetic mutations crucial for both diagnostic purposes and research. For example, in January 2023, Qiagen, a medical devices and health care company based in Germany, launched its CLC genomics workbench premium, which incorporates lightspeed technology. This allows for the efficient analysis of both whole genome sequencing (WGS) and whole exome sequencing (WES) data. This innovation processes an entire genome in just 25 minutes for about $1 using cloud computing, while also offering support for local hardware. By significantly reducing both time and associated costs, lightSpeed thereby improves the accessibility of large-scale genetic testing in the WES market.
Who Are The Top Companies Competing In The Whole Exome Sequencing Market?
Major companies operating in the whole exome sequencing market are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.
Read the full whole exome sequencing market report here:
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
Which Geographic Regions Are Influencing Demand In The Whole Exome Sequencing Market?
North America was the largest region in the whole exome sequencing market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Whole Exome Sequencing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp
Browse Through More Reports Similar to the Global Whole Exome Sequencing Market 2026, By The Business Research Company
Whole Genome And Exome Sequencing Global Market Report
Next Generation Sequencing Market
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Protein Sequencing Global Market Report
https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model